{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:50:46Z","timestamp":1794559846911,"version":"4.9.1"},"reference-count":25,"publisher":"American Association for Cancer Research (AACR)","issue":"2","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Whole-body hyperthermia (WBHT) is a promising therapy for advanced malignancies, including metastatic pancreatic ductal adenocarcinoma (PDAC). This first-in-human study evaluated the safety and tolerability of repeated WBHT sessions at 41.50\u00b0C for various treatment durations and in combination with standard-of-care chemotherapy regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>Twelve patients with advanced solid tumors, primarily metastatic PDAC, completed the study. WBHT was administered using an innovative medical device (TempoCure, ElmediX) as monotherapy or with standard-of-care chemotherapy in escalating durations of 2, 4, and 6 hours, in four cohorts. Safety was assessed through adverse event (AE) monitoring, serious AE (SAE) reporting, and comprehensive clinical and laboratory evaluations up to a 10-week follow-up. Tolerability was evaluated according to whether patients were able to complete all planned WBHT cycles, with or without concomitant chemotherapy, without the need for dose modifications or treatment interruptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The WBHT treatment was well tolerated, with most patients completing scheduled treatments despite advanced disease. The most frequent AEs were fatigue, hypokalemia, nausea, and diarrhea. Initial decubitus ulcers led to improved patient handling protocols. No clear increase in AE or SAE incidence was associated with longer WBHT durations or chemotherapy combination. The trend toward fewer AEs in later treatments likely reflects a procedural learning curve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>WBHT administered with the TempoCure system at 41.50\u00b0C for 2, 4, and 6 hours is safe and tolerable alone or in combination with chemotherapy, in patients with advanced cancer refractory to prior treatments. These findings support further investigation in upcoming randomized trials designed to evaluate efficacy in metastatic PDAC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>The MATTERS trial demonstrates that WBHT at 41.50\u00b0C, delivered with the TempoCure device, is a safe and well-tolerated treatment for advanced malignancies, particularly in patients with refractory metastatic PDAC. These findings support the integration of WBHT with standard chemotherapy regimens, paving the way for future efficacy trials aimed at improving therapeutic outcomes in challenging cancer populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0660","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:01:48Z","timestamp":1770192108000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50\u00b0C in Combination with Chemotherapy in Metastatic Cancer Patients"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-5445","authenticated-orcid":false,"given":"Luigi","family":"Brancato","sequence":"first","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2276-379X","authenticated-orcid":false,"given":"Ivana","family":"Gorbaslieva","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."},{"id":[{"id":"https:\/\/ror.org\/01hwamj44","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Antwerp 3 Department of Hepatobiliary, Transplant and Endocrine Surgery, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-3218","authenticated-orcid":false,"given":"Oleg","family":"Rudenko","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0812-131X","authenticated-orcid":false,"given":"Tine","family":"Logghe","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."},{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3152-8903","authenticated-orcid":false,"given":"Eke","family":"van Zwol","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1295-6973","authenticated-orcid":false,"given":"Ga\u00eblle","family":"Boulet","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."},{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2643-2790","authenticated-orcid":false,"given":"Laurent","family":"Van den Bossche","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-6368","authenticated-orcid":false,"given":"Johan","family":"Van den Bossche","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4969-2303","authenticated-orcid":false,"given":"Marc","family":"Peeters","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-2278","authenticated-orcid":false,"given":"Thiery","family":"Chapelle","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."},{"id":[{"id":"https:\/\/ror.org\/01hwamj44","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Antwerp 3 Department of Hepatobiliary, Transplant and Endocrine Surgery, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5151-8999","authenticated-orcid":false,"given":"Vera","family":"Saldien","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."},{"id":[{"id":"https:\/\/ror.org\/01hwamj44","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Antwerp 4 Department of Anesthesiology, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-037X","authenticated-orcid":false,"given":"Peter","family":"Vueghs","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."},{"name":"5Department of Anesthesiology, AZ Vitaz, Sint-Niklaas, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-5305","authenticated-orcid":false,"given":"Timon","family":"Vandamme","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."},{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 6 Center of Oncological Research (CORE), Faculty of Medicine and Health Sciences, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3323-0651","authenticated-orcid":false,"given":"Rowan","family":"Dankerlui","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."},{"id":[{"id":"https:\/\/ror.org\/01hwamj44","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Antwerp 4 Department of Anesthesiology, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-6994","authenticated-orcid":false,"given":"Dirk","family":"Ysebaert","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."},{"id":[{"id":"https:\/\/ror.org\/01hwamj44","id-type":"ROR","asserted-by":"publisher"}],"name":"University Hospital Antwerp 3 Department of Hepatobiliary, Transplant and Endocrine Surgery, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9107-132X","authenticated-orcid":false,"given":"Johannes","family":"Bogers","sequence":"additional","affiliation":[{"name":"1ElmediX NV, Leuven, Belgium."},{"id":[{"id":"https:\/\/ror.org\/008x57b05","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Antwerp 2 Faculty of Medicine and Health Sciences, , Antwerp, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"2026030409313964100_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/bjc.1974.152","article-title":"Proceedings: the effect of whole body hyperthermia in advanced cancer","volume":"30","author":"Pettigrew","year":"1974","journal-title":"Br J Cancer"},{"key":"2026030409313964100_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.4.5946.679","article-title":"Clinical effects of whole-body hyperthermia in advanced malignancy","volume":"4","author":"Pettigrew","year":"1974","journal-title":"Br Med J"},{"key":"2026030409313964100_bib3","doi-asserted-by":"crossref","first-page":"e28488","DOI":"10.1016\/j.heliyon.2024.e28488","article-title":"Hyperthermia improves gemcitabine sensitivity of pancreatic cancer cells by suppressing the EFNA4\/\u03b2-catenin Axis and activating dCK","volume":"10","author":"He","year":"2024","journal-title":"Heliyon"},{"key":"2026030409313964100_bib4","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.3390\/cancers16213656","article-title":"Combined radiotherapy and hyperthermia: a systematic review of immunological synergies for amplifying radiation-induced abscopal effects","volume":"16","author":"Van Dieren","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026030409313964100_bib5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","volume":"363","author":"Li","year":"2004","journal-title":"Lancet"},{"key":"2026030409313964100_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/OP.22.00328","article-title":"Pancreatic adenocarcinoma management","volume":"19","author":"Jiang","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"2026030409313964100_bib7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"key":"2026030409313964100_bib8","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"2026030409313964100_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13193-014-0316-5","article-title":"Review: the role of hyperthermia in treating pancreatic tumors","volume":"6","author":"Roesch","year":"2015","journal-title":"Indian J Surg Oncol"},{"key":"2026030409313964100_bib10","first-page":"109","article-title":"The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas","volume":"27","author":"Rogers","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"2026030409313964100_bib11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ctrv.2015.05.009","article-title":"Local hyperthermia combined with radiotherapy and-\/or chemotherapy: recent advances and promises for the future","volume":"41","author":"Datta","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"2026030409313964100_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2020.01.003","article-title":"Molecular and biological rationale of hyperthermia as radio- and chemosensitizer","volume":"163\u2013164","author":"Oei","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"2026030409313964100_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/cancers16030505","article-title":"Hyperthermia in combination with emerging targeted and immunotherapies as a new approach in cancer treatment","volume":"16","author":"Logghe","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026030409313964100_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/02656736.2017.1401126","article-title":"The clinical benefit of hyperthermia in pancreatic cancer: a systematic review","volume":"34","author":"van der Horst","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"2026030409313964100_bib15","doi-asserted-by":"crossref","first-page":"1487296","DOI":"10.3389\/fimmu.2025.1487296","article-title":"From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy","volume":"16","author":"Abreu","year":"2025","journal-title":"Front Immunol"},{"key":"2026030409313964100_bib16","doi-asserted-by":"crossref","first-page":"102615","DOI":"10.1016\/j.jtherbio.2020.102615","article-title":"Hyperthermia and protein homeostasis: cytoprotection and cell death","volume":"91","author":"Ahmed","year":"2020","journal-title":"J Therm Biol"},{"key":"2026030409313964100_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/02656736.2010.534527","article-title":"Thresholds for thermal damage to normal tissues: an update","volume":"27","author":"Yarmolenko","year":"2011","journal-title":"Int J Hyperthermia"},{"key":"2026030409313964100_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/biom12050651","article-title":"Hyperthermia enhances efficacy of chemotherapeutic agents in pancreatic cancer cell lines","volume":"12","author":"Maurici","year":"2022","journal-title":"Biomolecules"},{"key":"2026030409313964100_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/02656736.2021.1876256","article-title":"Safety evaluation of long-term temperature controlled whole-body thermal treatment in female Aachen minipig","volume":"38","author":"Carneiro","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"2026030409313964100_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/02656736.2021.2000649","article-title":"Tolerability of long-term temperature controlled whole-body thermal treatment in advanced cancer-bearing dogs","volume":"39","author":"Wylleman","year":"2022","journal-title":"Int J Hyperthermia"},{"key":"2026030409313964100_bib21","volume-title":"Evaluation of thermal effects of medical devices that produce tissue heating and\/or cooling","author":"FDA","year":"2024"},{"key":"2026030409313964100_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/02656730500204487","article-title":"Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment","volume":"21","author":"Song","year":"2005","journal-title":"Int J Hyperthermia"},{"key":"2026030409313964100_bib23","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.ejca.2008.07.038","article-title":"Hyperthermia adds to chemotherapy","volume":"44","author":"Issels","year":"2008","journal-title":"Eur J Cancer"},{"key":"2026030409313964100_bib24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdf280","article-title":"Heating the patient: a promising approach?","volume":"13","author":"van der Zee","year":"2002","journal-title":"Ann Oncol"},{"key":"2026030409313964100_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/02656730500532028","article-title":"Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field","volume":"22","author":"Kampinga","year":"2006","journal-title":"Int J Hyperthermia"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/2\/273\/3735425\/crc-25-0660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/2\/273\/3735425\/crc-25-0660.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T14:31:44Z","timestamp":1772634704000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/2\/273\/774185\/The-MATTERS-Trial-Safety-and-Tolerability-of-Whole"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0660","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.31248719","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248728","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31496238","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248716","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248704","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248713","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248701","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248722","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248710","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31496241","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31248698","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8289893","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}